Pazopanib, Another Drug in the Arsenal of Weapons Against Renal Cell Cancer – ESMO 2012

Pazopanib, another drug in the arsenal of weapons against renal cell cancer – ESMO 2012 — Cora Sternberg describes an interesting phase III study confirming the positive results for a new drug in RCC treatment. This study was presented during ESMO…

Find More Drug Treatment News 2010 Information…